Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Elios Biotechnology (Shanghai)

Request full access

Filtration-based separation and purification solutions for pharmaceuticals

Jing'an District, ChinaFounded 2021Biotech & Life Sciences

About Elios Biotechnology (Shanghai)

Alioth Biotech, founded in Shanghai in 2021 by Jia Qijun, develops and manufactures filtration-based products for pharmaceutical processing. The company aims to provide high-quality separation and purification solutions that comply with both domestic and international regulations. Alioth serves pharmaceutical manufacturers by helping them meet regulatory standards, improve production safety, and optimize their bioprocess workflows.

The company operates with a global footprint, featuring R&D centers in Boston, USA, and Shanghai, China, alongside production facilities in Shanghai and Hangzhou. This international structure is led by a team with extensive experience in membrane and filtration technology, focusing on securing the supply chain and enhancing drug manufacturing safety for pharmaceutical companies worldwide. The leadership team, including founder and CEO Jia Qijun, possesses over a decade of management experience from leading multinational life science enterprises.

Since its inception, Alioth has secured several hundred million yuan through multiple funding rounds. Notable financing includes a Series A round in October 2022 from Matrix Partners China and Legend Capital, a Series A+ round in October 2023 led by the AstraZeneca-CICC Fund, and a Series A++ round in September 2025 that raised over RMB 100 million, led by Lapam Capital. These funds are directed towards the R&D of filtration membrane materials and the commercialization of its filter products. The company's product portfolio includes cartridge filters, capsule filters, depth filters, and filtration hardware systems, catering to applications like blood products, vaccines, and monoclonal antibodies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
23
Open positions
None listed
Dealroom signal
86.0/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Sep 2025 $14M $55M Longpan Investment · Guohai Innovation Capital ↗
SERIES A✓Equity / VC Oct 2023 $14M $55M AstraZeneca Pharmaceutical · Yi Shuishuishan · Legend Capital · Matrix Partners China ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Elios Biotechnology (Shanghai) website traffic

Latest recorded traffic for Elios Biotechnology (Shanghai) is 1.5K monthly website visits, up 78.6% over the last three months. Elios Biotechnology (Shanghai)'s team grew 21.1% over the past year.

Latest monthly visits1.5K 3-month web change+78.6% 1-year team growth+21.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Elios Biotechnology (Shanghai) in the Jing'an District ecosystem

Live from Dealroom

The Elios Biotechnology (Shanghai) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Jing'an District HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Elios Biotechnology (Shanghai) on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Elios Biotechnology (Shanghai)’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.